Evidence map›Paper›PMID 39302533›Full record

GuidelineCardiovascular intervention and therapeutics2024

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.

Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Yoshio Kobayashi, Tetsuya Amano, Takashi Muramatsu, Hideki Ishii, Kyohei Yamaji, Shun Kohsaka, Tevfik F Ismail and 38 more

Registry-linked trialAbstract readPractice GuidelineConsensus Statement
In one paragraph

Guideline in Cardiovascular intervention and therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06640400 (A Clinical Study of the Efficacy of Cardiovascular Ultrasound Therapy on the Rehabilitation of Patients After PCI for Coronary Artery Disease), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06640400 nanot yet recruitingnot on this map

A Clinical Study of the Efficacy of Cardiovascular Ultrasound Therapy on the Rehabilitation of Patients After PCI for Coronary Artery Disease

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2024 to 2025Enrolled200ConditionsCoronary Heart DiseaseArmsCardiovascular ultrasound
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Dual Artery Compression for Patent Hemostasis and Prevention of Radial Artery Occlusion: The Quebec TerryCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Yukio OzakiDepartment of Cardiology, Fujita Health University Okazaki Medical Center, Fujita Health University School of Medicine, 1-98 Dengaku, Kutsukake, Toyoake, Aichi, 470-1192, Japan. yukio.ozaki7@gmail.com.
Akihiro TobeDepartment of Cardiology, University of Galway, Galway, Ireland.
Yoshinobu OnumaDepartment of Cardiology, University of Galway, Galway, Ireland.
Yoshio KobayashiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Tetsuya AmanoDepartment of Cardiology, Aichi Medical University, Nagakute, Japan.
Takashi MuramatsuDepartment of Cardiology, Fujita Health University Okazaki Medical Center, Fujita Health University School of Medicine, 1-98 Dengaku, Kutsukake, Toyoake, Aichi, 470-1192, Japan.
Hideki IshiiDepartment of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Kyohei YamajiDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Tevfik F IsmailKing's College London, London, UK.
Shiro UemuraCardiovascular Medicine, Kawasaki Medical School, Kurashiki, Japan.
Yutaka HikichiHeart Center, Saga Medical Center Koseikan, Saga, Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Junya AkoDepartment of Cardiology, Kitasato University Hospital, Sagamihara, Japan.
Yoshihiro MorinoDepartment of Cardiology, Iwate Medical University Hospital, Shiwa, Japan.
Yuichiro MaekawaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Toshiro ShinkeDivision of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Junya ShiteCardiology Division, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
Yasumi IgarashiDivision of Cardiology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Yoshihisa NakagawaDivision of Cardiovascular Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Nobuo ShiodeDivision of Cardiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Atsunori OkamuraDivision of Cardiology, Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Japan.
Takayuki OgawaDivision of Cardiology, The Jikei University School of Medicine, Tokyo, Japan.
Yoshisato ShibataDivision of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.
Takafumi TsujiKusatsu Heart Center, Kusatsu, Japan.
Kentaro HayashidaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Junji YajimaDepartment of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.
Teruyasu SuganoDivision of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Hiroyuki OkuraDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
Hideki OkayamaDivision of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Katsuhiro KawaguchiDepartment of Cardiology, Komaki City Hospital, Komaki, Japan.
Kan ZenDepartment of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Saeko TakahashiDivision of Cardiology, Tokushukai Shonan Oiso Hospital, Oiso, Japan.
Toshihiro TamuraDivision of Cardiology, Tenri Hospital, Tenri, Japan.
Kazuhiko NakazatoDepartment of Cardiology, Fukushima Medical University Hospital, Fukushima, Japan.
Junichi YamaguchiDepartment of Cardiology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Osamu IidaCardiovascular Division, Osaka Police Hospital, Osaka, Japan.
Reina OzakiDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Fuminobu YoshimachiDepartment of Cardiology, Tokai University Hachioji Hospital, Hachioji, Japan.
Masaharu IshiharaDepartment of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Toyoaki MuroharaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takafumi UenoDivision of Cardiology, Marin Hospital, Fukuoka, Japan.
Hiroyoshi YokoiCardiovascular Center, Fukuoka Sanno Hospital, Fukuoka, Japan.
Masato NakamuraDivision of Cardiovascular Medicine, Ohashi Medical Center, Toho University School of Medicine, Tokyo, Japan.
Yuji IkariDepartment of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Patrick W SerruysDepartment of Cardiology, University of Galway, Galway, Ireland.
Ken KozumaDepartment of Cardiology, Teikyo University Hospital, Tokyo, Japan.
Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention, Therapeutics (CVIT)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include: (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.

Indexed as

Acute Coronary SyndromeConsensusPercutaneous Coronary InterventionHumansJapanPlatelet Aggregation InhibitorsST Elevation Myocardial InfarctionPlatelet Aggregation InhibitorsAcute coronary syndrome (ACS)Non-ST-segment elevation acute coronary syndrome (NSTE-ACS)Non-ST-segment elevation acute myocardial infarction (NSTEMI)Percutaneous coronary intervention (PCI)ST-segment elevation acute my cardial infarction (STEMI)

Identifiers

PMID39302533
PMCPMC11436458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.